Clinical Trials
234 trialsPACHA-02
UNICANCER
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
NUTRICOLOR
Istituto Clinico Humanitas
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
Xijing Hospital
COLIBRI-GI
UNICANCER
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Beijing DCTY Biotech Co.,Ltd.
IGNITE-CRC
National Cancer Center Hospital East
TCR1188-ABC Cells in KRAS-mutated Cancers
University of Pennsylvania
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients
Sir Run Run Shaw Hospital
Histidine and Immunotherapy Response in Colorectal Cancer
Shanghai Jiao Tong University School of Medicine
ODI-2001-01
Centre Georges Francois Leclerc
A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases
The First Hospital of Jilin University
CRIS
University Hospital, Ghent
A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer
Hebei Medical University Fourth Hospital
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
A Phase I Trial of S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas
Cedars-Sinai Medical Center
AIC-DC
University of Oklahoma
Effects of Berberine on the Human Gut Microbiome
Shanghai Jiao Tong University School of Medicine
Histidine Supplementation for Antitumor Immunity in Colorectal Cancer
Shanghai Jiao Tong University School of Medicine
Secondary Care Colorectal Cancer Pathway Review
University of Edinburgh
PREDIPER
Assistance Publique - Hôpitaux de Paris
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Fred Hutchinson Cancer Center
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Cedars-Sinai Medical Center
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CoSMMO
University of Colorado, Denver
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases
Tianjin Medical University Cancer Institute and Hospital
OPT-EPA
University of Edinburgh
OPTIMAL
Karolinska Institutet
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
Vejle Hospital
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Icahn School of Medicine at Mount Sinai
TRIUNITE06
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
Scripps Health
HRCC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
BEST
Shanghai Zhongshan Hospital
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Guardant Shield Colorectal Cancer Screening
University of Miami
Colorectal Adenoma Cohort
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collagenase Biobank Study
University of Chicago
SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study
West China Hospital
FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.
Zhongnan Hospital
ACURE
Chang Gung Memorial Hospital
AIRC_ IG 34634
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer
Shanghai 10th People's Hospital
PREDU
University of Vic - Central University of Catalonia
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer
Huazhong University of Science and Technology
Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue
Chang Gung Memorial Hospital
Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses
Jules Bordet Institute
TRIUNITE-07
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer
Sun Yat-sen University